Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A02354 | 34405583 | Nurs Open | A qualitative study of self-management experiences in people with non-alcoholic fatty liver disease. | 2021 | Details |
A02355 | 34405221 | Sheng Li Xue Bao | [Arachidonic acid metabolism in liver glucose and lipid homeostasis]. | 2021 | Details |
A02356 | 34405211 | Sheng Li Xue Bao | [n-3 Polyunsaturated fatty acid attenuates hyperhomocysteinemia-induced hepatic steatosis by increasing hepatic LXA5 content]. | 2021 | Details |
A02357 | 34404856 | Sci Rep | Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study. | 2021 | Details |
A02358 | 34404276 | Crit Rev Food Sci Nutr | Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut-liver axis. | 2021 | Details |
A02359 | 34403877 | Phytomedicine | A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation. | 2021 | Details |
A02360 | 34403664 | Environ Res | Lead, mercury, and cadmium exposures are associated with obesity but not with diabetes mellitus: Korean National Environmental Health Survey (KoNEHS) 2015-2017. | 2021 | Details |
A02362 | 34402795 | JMIR Form Res | Utilization of a Directly Supervised Telehealth-Based Exercise Training Program in Patients With Nonalcoholic Steatohepatitis: Feasibility Study. | 2021 | Details |
A02363 | 34402473 | Eur J Gastroenterol Hepatol | Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression. | 2021 | Details |
A02364 | 34401974 | Cell Biol Toxicol | Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in acetaminophen-induced acute liver injury. | 2021 | Details |
A02365 | 34401690 | JHEP Rep | Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication. | 2021 | Details |
A02366 | 34401141 | Ann Med Surg (Lond) | Prevalence of fatty liver disease and its associated factors among Jordanian patients with type 2 diabetes mellitus: A cross-sectional study. | 2021 | Details |
A02367 | 34400897 | Int J Med Sci | Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes. | 2021 | Details |
A02368 | 34400878 | Int J Med Sci | Relationship between the Metabolic Associated Fatty Liver Disease and Endometrial Thickness in Postmenopausal Women: A Cross-sectional Study in China. | 2021 | Details |
A02369 | 34400217 | Metabolism | Diabetes and metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
A02370 | 34400208 | J Pediatr | Relationship of Enhanced Liver Fibrosis Score with Pediatric Nonalcoholic Fatty Liver Disease Histology and Response to Vitamin E or Metformin. | 2021 | Details |
A02372 | 34400007 | Clin Ther | Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications. | 2021 | Details |
A02373 | 34399601 | Int J Immunopathol Pharmacol | Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice. | 2022 | Details |
A02374 | 34399486 | Food Res Int | Protective and ameliorating effects of probiotics against diet-induced obesity: A review. | 2021 | Details |
A02375 | 34399465 | Food Res Int | Regulatory effects of Lactobacillus fermented black barley on intestinal microbiota of NAFLD rats. | 2021 | Details |
A02376 | 34398492 | Aliment Pharmacol Ther | Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes. | 2021 | Details |
A02377 | 34397849 | Medicine (Baltimore) | Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease. | 2021 | Details |
A02378 | 34397807 | Medicine (Baltimore) | Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease: What should we expect from a meta-analysis? | 2021 | Details |
A02379 | 34397640 | Eur J Gastroenterol Hepatol | The role of mean platelet volume in nonalcoholic fatty liver disease without cardiovascular comorbidities, obesity and diabetes mellitus. | 2021 | Details |
A02380 | 34396890 | Arch Physiol Biochem | Hepatoprotection of capsaicin in alcoholic and non-alcoholic fatty liver diseases. | 2021 | Details |
A02381 | 34396467 | Rev Endocr Metab Disord | Applications of artificial intelligence (AI) in researches on non-alcoholic fatty liver disease(NAFLD) : A systematic review. | 2021 | Details |
A02382 | 34396022 | J Endocr Soc | Liver Fibrosis Indices for the Prediction of Mortality in Korean Subjects: A 16-Year Prospective Cohort Study. | 2021 | Details |
A02383 | 34395490 | Front Nutr | Broccoli Florets Supplementation Improves Insulin Sensitivity and Alters Gut Microbiome Population-A Steatosis Mice Model Induced by High-Fat Diet. | 2021 | Details |
A02384 | 34395461 | Front Med (Lausanne) | Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease. | 2021 | Details |
A02385 | 34394332 | PPAR Res | Computational Analysis of Gly482Ser Single-Nucleotide Polymorphism in PPARGC1A Gene Associated with CAD, NAFLD, T2DM, Obesity, Hypertension, and Metabolic Diseases. | 2021 | Details |
A02386 | 34394242 | Afr Health Sci | Association between APOC3 polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis. | 2020 | Details |
A02387 | 34393826 | Front Physiol | Similarities and Differences: A Comparative Review of the Molecular Mechanisms and Effectors of NAFLD and AFLD. | 2021 | Details |
A02388 | 34393793 | Front Pharmacol | Extracts of Vine Tea Improve Diet-Induced Non-Alcoholic Steatohepatitis Through AMPK-LXRα Signaling. | 2021 | Details |
A02389 | 34392687 | J Agric Food Chem | Understanding Choline Bioavailability and Utilization: First Step Toward Personalizing Choline Nutrition. | 2021 | Details |
A02391 | 34391652 | J Cardiothorac Vasc Anesth | Management of Patients With Non-alcoholic Steatohepatitis Undergoing Liver Transplantation: Considerations for the Anesthesiologist. | 2021 | Details |
A02392 | 34390865 | Cell Mol Gastroenterol Hepatol | E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9. | 2021 | Details |
A02393 | 34390493 | Eur J Clin Invest | Mushrooms on the plate: Trends towards NAFLD treatment, health improvement and sustainable diets. | 2021 | Details |
A02394 | 34390467 | Genes Genomics | microRNA profiles of serum exosomes derived from children with nonalcoholic fatty liver. | 2021 | Details |
A02395 | 34389163 | Surgery | The role of bilio-pancreatic limb in nonalcoholic steatohepatitis improvement after duodenal-jejunal bypass in rats. | 2021 | Details |
A02396 | 34389043 | Clin Epigenetics | A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver disease. | 2021 | Details |
A02397 | 34387896 | Hepatology | Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice. | 2021 | Details |
A02398 | 34387409 | Diabetes Obes Metab | A clinical overview of non-alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications-What the non-specialist needs to know. | 2021 | Details |
A02399 | 34386935 | Hepatol Int | First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients. | 2021 | Details |
A02400 | 34386604 | JGH Open | The ultrasound-guided attenuation parameter is useful in quantification of hepatic steatosis in non-alcoholic fatty liver disease. | 2021 | Details |
A02401 | 34386600 | JGH Open | Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes. | 2021 | Details |
A02402 | 34385479 | Sci Rep | Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study. | 2021 | Details |
A02403 | 34385447 | Nat Commun | Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma. | 2021 | Details |
A02404 | 34384788 | J Lipid Res | Nonalcoholic fatty liver disease stratification by liver lipidomics. | 2021 | Details |
A02405 | 34384674 | Asian J Surg | Non-alcoholic fatty liver disease and obesity among adult donors are major challenges to living-donor liver transplantation: A single-center experience. | 2021 | Details |
A02406 | 34384565 | J Pharmacol Sci | Protective effect of SGL5213, a potent intestinal sodium-glucose cotransporter 1 inhibitor, in nonalcoholic fatty liver disease in mice. | 2021 | Details |
A02407 | 34383741 | PLoS Comput Biol | Bistability in fatty-acid oxidation resulting from substrate inhibition. | 2021 | Details |
A02408 | 34383355 | Int J Clin Pract | The effects of Cynara scolymus L. supplementation on liver enzymes: A systematic review and meta-analysis. | 2021 | Details |
A02410 | 34383198 | Dig Dis Sci | Environmental Toxicants and NAFLD: A Neglected yet Significant Relationship. | 2021 | Details |
A02411 | 34383111 | Calcif Tissue Int | Neuregulin 4 Attenuates Osteoarthritis Progression by Inhibiting Inflammation and Apoptosis of Chondrocytes in Mice. | 2021 | Details |
A02412 | 34382947 | Am J Gastroenterol | Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
A02413 | 34382907 | Autophagy | Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy. | 2021 | Details |
A02414 | 34382495 | Ann Med | Effects of PPM1K rs1440581 and rs7678928 on serum branched-chain amino acid levels and risk of cardiovascular disease. | 2021 | Details |
A02415 | 34381984 | JHEP Rep | The role of cGAS-STING signalling in liver diseases. | 2021 | Details |
A02416 | 34381983 | JHEP Rep | Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. | 2021 | Details |
A02417 | 34381424 | Front Endocrinol (Lausanne) | Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population. | 2021 | Details |
A02418 | 34381196 | Nat Rev Endocrinol | GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. | 2021 | Details |
A02419 | 34380696 | Diabetes | Critical Role for Hepatocyte-Specific eNOS in NAFLD and NASH. | 2021 | Details |
A02420 | 34380057 | J Hepatol | Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States. | 2021 | Details |
A02422 | 34377148 | Therap Adv Gastroenterol | Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation. | 2021 | Details |
A02423 | 34375691 | Pharmacol Ther | Xyloketal B: A marine compound with medicinal potential. | 2021 | Details |
A02424 | 34375373 | J Gastrointestin Liver Dis | Liver-related Mortality is Increased in Lean Subjects with Non- alcoholic Fatty Liver Disease Compared to Overweight and Obese Subjects. | 2021 | Details |
A02425 | 34374782 | Inflamm Bowel Dis | The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis. | 2022 | Details |
A02426 | 34374658 | J Physiol Pharmacol | Hesperidin, a novel candidate for the successful treatment of high fat diet plus ethanol-induced fatty liver disease in mice. | 2021 | Details |
A02427 | 34374436 | J Pathol | The loss of histone deacetylase 4 in macrophages exacerbates hepatic and adipose tissue inflammation in male but not in female mice with diet-induced non-alcoholic steatohepatitis. | 2021 | Details |
A02428 | 34374253 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | [Effects of GPR81 agonist on insulin resistance in rats with nonalcoholic fatty liver disease]. | 2021 | Details |
A02429 | 34374198 | J Dig Dis | Serum syndecan-4 is associated with nonalcoholic fatty liver disease. | 2021 | Details |
A02431 | 34373137 | Ultrasound Med Biol | Improved Ultrasound Attenuation Measurement Method for the Non-invasive Evaluation of Hepatic Steatosis Using FibroScan. | 2021 | Details |
A02432 | 34372774 | BMC Gastroenterol | Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study. | 2021 | Details |
A02433 | 34372627 | Diabetes Metab J | Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study. | 2021 | Details |
A02434 | 34372491 | Viruses | Findings from Studies Are Congruent with Obesity Having a Viral Origin, but What about Obesity-Related NAFLD? | 2021 | Details |
A02435 | 34371968 | Nutrients | The Emerging Role of Sfrp5 and Wnt5a in the Pathogenesis of Obesity: Implications for a Healthy Diet and Lifestyle. | 2021 | Details |
A02436 | 34371959 | Nutrients | Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS). | 2021 | Details |
A02437 | 34371946 | Nutrients | Expression of Jejunal Taste Receptors in Women with Morbid Obesity. | 2021 | Details |
A02438 | 34371891 | Nutrients | Coffee Consumption and the Progression of NAFLD: A Systematic Review. | 2021 | Details |
A02439 | 34371545 | Zhonghua Gan Zang Bing Za Zhi | [Research progress of hepatic non-parenchymal cells in nonalcoholic steatohepatitis]. | 2021 | Details |
A02440 | 34371198 | Prostaglandins Other Lipid Mediat | Lipocalin-type Prostaglandin D2 Synthase appears to function as a Novel Adipokine Preventing Adipose Dysfunction in response to a High Fat Diet. | 2021 | Details |
A02441 | 34371126 | J Nutr Biochem | Dietary citrate acutely induces insulin resistance and markers of liver inflammation in mice. | 2021 | Details |
A02442 | 34370929 | Biomol Concepts | Insulin resistance is positively associated with plasma cathepsin D activity in NAFLD patients. | 2021 | Details |
A02443 | 34370218 | Clin J Gastroenterol | Efficacy of elafibranor in patients with liver abnormalities especially non-alcoholic steatohepatitis: a systematic review and meta-analysis. | 2021 | Details |
A02444 | 34370215 | World J Pediatr | Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity. | 2021 | Details |
A02445 | 34369032 | J Biochem Mol Toxicol | Shc inhibitor idebenone ameliorates liver injury and fibrosis in dietary NASH in mice. | 2021 | Details |
A02446 | 34368214 | Front Nutr | Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2021 | Details |
A02447 | 34367629 | J Nutr Sci | Mediterranean dietary pattern and non-alcoholic fatty liver diseases: a case-control study. | 2021 | Details |
A02448 | 34367500 | World J Hepatol | Prevalence and risk factors of steatosis and advanced fibrosis using transient elastography in the United States' adolescent population. | 2021 | Details |
A02449 | 34367497 | World J Hepatol | Racial differences in prevalence and severity of non-alcoholic fatty liver disease. | 2021 | Details |
A02450 | 34366886 | Front Physiol | Serum Adropin as a Potential Biomarker for Predicting the Development of Type 2 Diabetes Mellitus in Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease. | 2021 | Details |
A02451 | 34366846 | Front Pharmacol | Metformin Alleviates Hepatic Steatosis and Insulin Resistance in a Mouse Model of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Promoting Transcription Factor EB-Dependent Autophagy. | 2021 | Details |
A02453 | 34366233 | J Nutr Educ Behav | What's in Your Drink? Poster Educates Families About Sugar Content and Fatty Liver Disease. | 2021 | Details |
A02454 | 34365735 | Obesity (Silver Spring) | Preparing for the NASH epidemic: A call to action. | 2021 | Details |
A02455 | 34365685 | FASEB J | Melatonin induces Nrf2-HO-1 reprogramming and corrections in hepatic core clock oscillations in Non-alcoholic fatty liver disease. | 2021 | Details |
A02457 | 34365005 | Magn Reson Imaging | Influence of arm position on proton density fat fraction in the liver using chemical shift-encoded magnetic resonance imaging. | 2021 | Details |
A02458 | 34364973 | Biochim Biophys Acta Gen Subj | Copper and lipid metabolism: A reciprocal relationship. | 2021 | Details |
A02459 | 34364885 | Arch Biochem Biophys | Tetraspanin TM4SF5 in hepatocytes negatively modulates SLC27A transporters during acute fatty acid supply. | 2021 | Details |
A02460 | 34364544 | Lancet Gastroenterol Hepatol | Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. | 2021 | Details |
A02461 | 34363981 | Diabetes Metab | Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement. | 2021 | Details |